Cargando…

Multidisciplinary development of guidelines for ketamine treatment for treatment-resistant major depression disorder for use by adult specialist mental health services in New Zealand

BACKGROUND: The evidence base for racemic ketamine treatment for treatment-resistant major depressive disorder (TRD) continues to expand, but there are major challenges translating this evidence base into routine clinical care. AIM: To prepare guidelines for ketamine treatment of TRD that are suitab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaglehole, Ben, Glue, Paul, Clarke, Mike, Porter, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594164/ https://www.ncbi.nlm.nih.gov/pubmed/37828915 http://dx.doi.org/10.1192/bjo.2023.577

Ejemplares similares

Ketamine and psychotherapy for the treatment of psychiatric disorders: systematic review
por: Kew, Bess M., et al.
Publicado: (2023)

Impact of diagnosis on outcomes for compulsory treatment orders in New Zealand
por: Beaglehole, Ben, et al.
Publicado: (2022)

The association between Compulsory Community Treatment Order status and mortality in New Zealand
por: Beaglehole, Ben, et al.
Publicado: (2023)

Compulsory Community Treatment Orders in New Zealand and the provision of care: An examination of national databases and predictors of outcome
por: Beaglehole, Ben, et al.
Publicado: (2021)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment‐Refractory Depression
por: Abuhelwa, Ahmad Y., et al.
Publicado: (2022)

Are Specialist Treatment Services Needed for Doctors with Mental Health Problems?
por: George, Sanju, et al.
Publicado: (2020)

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders
por: Whittaker, Elizabeth, et al.
Publicado: (2021)

Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety
por: Shadli, Shabah Mohammad, et al.
Publicado: (2018)

Ketamine and neuroticism: a double-hit hypothesis of internalizing disorders
por: McNaughton, N., et al.
Publicado: (2020)

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study
por: Glue, Paul, et al.
Publicado: (2020)

Could ketamine be the answer to treating treatment-resistant major depressive disorder?
por: Ramadan, Abdullah Mohammed, et al.
Publicado: (2020)

Ketamine for the treatment of major depression: a systematic review and meta-analysis
por: Nikolin, Stevan, et al.
Publicado: (2023)

A neural network approach to optimising treatments for depression using data from specialist and community psychiatric services in Australia, New Zealand and Japan
por: Cousins, Aidan, et al.
Publicado: (2022)

Nutritional intake and foodservice satisfaction of adults receiving specialist inpatient mental health services
por: Porter, Judi, et al.
Publicado: (2022)

Evaluating 12 Years of Implementing a Multidisciplinary Specialist Child and Adolescent Obesity Treatment Service: Patient-Level Outcomes
por: Wyse, Cathy, et al.
Publicado: (2022)

Psychological distress, loneliness, alcohol use and suicidality in New Zealanders with mental illness during a strict COVID-19 lockdown
por: Bell, Caroline, et al.
Publicado: (2021)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Lessons from export to New Zealand of the second opinion appointed doctor scheme
por: Dawson, John, et al.
Publicado: (2015)

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
por: Xu, Ying, et al.
Publicado: (2015)

Real-World Treatment Costs and Care Utilization in Patients with Major Depressive Disorder With and Without Psychiatric Comorbidities in Specialist Mental Healthcare
por: Kan, Kaying, et al.
Publicado: (2021)

Integration of a Tobacco Treatment Specialist into Primary Care: Perception from Multidisciplinary Team
por: Meyer, Amanda F., et al.
Publicado: (2022)

The clinical nurse specialist's role in head and neck cancer care: United Kingdom National Multidisciplinary Guidelines
por: Dempsey, L, et al.
Publicado: (2016)

Silver linings of the COVID-19 lockdown in New Zealand
por: Jenkins, Matthew, et al.
Publicado: (2021)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Efficacy of ketamine therapy in the treatment of depression
por: Mandal, Suprio, et al.
Publicado: (2019)

Ketamine treatment for depression: a review
por: Yavi, Mani, et al.
Publicado: (2022)

Guidelines, process and ethics with the New Zealand Mental Health (compulsory assessment and treatment) Act: striking a balance
por: Gale, Christopher, et al.
Publicado: (2007)

Suicide Prevention Guideline Implementation in Specialist Mental Healthcare Institutions in The Netherlands
por: Mokkenstorm, Jan, et al.
Publicado: (2018)

Compulsory community treatment orders (CTOs): recent research and future directions
por: Beaglehole, Ben, et al.
Publicado: (2023)

AcceSS and Equity in Transplantation (ASSET) New Zealand: Protocol for population-wide data linkage platform to investigate equity in access to kidney failure health services in New Zealand
por: Cutting, Rachel B., et al.
Publicado: (2022)

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder
por: Murrough, J W, et al.
Publicado: (2015)

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
por: Gałuszko-Węgielnik, Maria, et al.
Publicado: (2023)

Right Frontal Theta: Is It a Response Biomarker for Ketamine’s Therapeutic Action in Anxiety Disorders?
por: Shadli, Shabah M., et al.
Publicado: (2022)

Challenges facing essential workers: a cross-sectional survey of the subjective mental health and well-being of New Zealand healthcare and ‘other’ essential workers during the COVID-19 lockdown
por: Bell, Caroline, et al.
Publicado: (2021)

Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines
por: Simo, R, et al.
Publicado: (2016)

"Attending to History" in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration
por: Perry, Catherine, et al.
Publicado: (2022)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
por: Shin, Cheolmin, et al.
Publicado: (2020)

Clinical Efficacy of Ketamine for Treatment-resistant Depression
por: Bratsos, Sosipatros, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2g5erchje7qer20hrnlo16s90m